c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
about
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsBasonuclin-2 requirements for zebrafish adult pigment pattern development and female fertilityA Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaMolecular pathogenesis of sporadic melanoma and melanoma-initiating cells.KGF Promotes Paracrine Activation of the SCF/c-KIT Axis from Human Keratinocytes to Melanoma Cells.A phase 2 trial of dasatinib in advanced melanoma.Molecular bases of cutaneous and uveal melanomas.Comparison of c-Kit expression between primary and metastatic melanoma of skin and mucosa.Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation.Molecular targets in melanoma: time for 'ethnic personalization'Targeting the RAS pathway in melanoma.Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence.Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers.Putative role of HIF transcriptional activity in melanocytes and melanoma biology.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaThe EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy.The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China.
P2860
Q26795735-A70AE4BD-0C46-4472-8350-2875B180DFA1Q27348522-5DBE8E3D-4951-4090-9FFB-3CF0C97D8BC2Q27851611-16891618-AFAA-43CD-80FE-F134C67D3828Q33725172-E6D195C2-A97B-49E8-BB4D-867EADC1841DQ33760584-E91B6449-826E-4270-B396-73D8AC7375DAQ35048145-21BD8619-385E-49DF-A2EE-CC3DF389CA13Q35174214-2B0B32C8-7CC3-482F-B6E1-C00CA34B711AQ35765288-020EEF01-C63A-420A-B1E3-69990D23DDB4Q36260662-F280217B-2A36-443D-B851-468558A6CF88Q36927065-D1E66384-A270-4010-ACDA-F6C854AF5920Q37137004-3AEB7F3B-C33A-4FB1-A8D6-C4F781DBE275Q37487029-31766A87-F8FA-4785-B5B2-575043313725Q37571141-A1FA6480-EE35-4AC7-8DEB-C5EB73DB102BQ38160223-71A86B9A-110A-4278-B0DE-47D2BF3981F3Q38259956-B842D8CD-5BF7-47D8-8CF6-428E3A2BE40CQ38549236-54F477CA-D4E5-4D40-81C3-56201C4A0C98Q40007423-A7E3597F-BB4F-4FD4-B808-E7DF4C3C76C0Q42110684-1EF003E0-5839-408E-898B-099F79BAA841Q42736022-109B1EF3-1CE3-4307-A802-9B06E6C4ED48Q47098177-4334867E-ADA9-4C7A-BC24-F2EC4BEFA11B
P2860
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@en
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@nl
type
label
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@en
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@nl
prefLabel
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@en
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@nl
P356
P1476
c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
@en
P2093
Jeffrey S Weber
Vernon K Sondak
P304
P356
10.14670/HH-24.643
P577
2009-05-01T00:00:00Z